Immunome (IMNM) SEC Filings & 10K Form

$13.73
-0.53 (-3.72%)
(As of 04/26/2024 ET)

Recent Immunome SEC Filings

DateFilerForm TypeView
04/26/2024
3:12 PM
Immunome (Filer)
Form ARS
04/25/2024
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
3:40 PM
Immunome (Filer)
Form S-3ASR
03/28/2024
3:04 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
8:07 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2024
8:10 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
1:10 PM
Alpine Global Management, LLC (Filed by)
Immunome (Subject)
Form SC 13G/A
02/06/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
8:18 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
7:50 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
7:53 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:27 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:33 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2024
4:37 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:40 PM
Immunome (Issuer)
Lapetina Bob (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:00 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
7:35 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:24 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/15/2023
6:28 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
11:15 PM
Immunome (Filer)
Form EFFECT
11/15/2023
5:03 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:52 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:23 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/09/2023
3:25 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
7:00 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
7:30 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
5:30 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:32 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:35 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2023
3:12 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
8:56 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
5:33 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
5:36 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2023
4:15 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G
10/12/2023
3:39 PM
Immunome Aggregator, LP (Filed by)
Immunome (Subject)
Form SC 13D
10/12/2023
3:46 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Wall Street Legend Issues New NVDA Warning (Ad)

Legendary Stockpicker: "Buy this A.I. stock NOW" His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.

Click here for the stock details
10/12/2023
3:02 PM
Barchas Isaac (Filed by)
Immunome (Subject)
Form SC 13D
10/12/2023
11:25 AM
EcoR1 Capital, LLC (Filed by)
Immunome (Subject)
Form SC 13G
10/04/2023
4:28 PM
Immunome (Issuer)
PRENDERGAST FRANKLYN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:29 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
4:32 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
4:34 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
4:35 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
5:56 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
4:50 PM
Immunome (Issuer)
RAPP MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2023
3:03 PM
Immunome (Subject)
Form 425
09/21/2023
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2023
11:15 PM
Immunome (Filer)
Form EFFECT
08/28/2023
8:10 AM
Immunome (Filer)
Form 424B3
08/25/2023
5:38 AM
Immunome (Filer)
Form S-4/A
08/09/2023
7:27 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
7:00 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/07/2023
7:39 AM
Immunome (Subject)
MorphImmune Inc. (Filed by)
Form SC 13D
07/05/2023
4:12 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
4:15 PM
Immunome (Subject)
Form 425
06/29/2023
3:45 PM
Immunome (Subject)
Form 425
06/29/2023
8:08 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
8:10 AM
Immunome (Subject)
Form 425
06/13/2023
4:00 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2023
3:47 PM
Giesing Dennis H (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:48 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:51 PM
Immunome (Issuer)
PRENDERGAST FRANKLYN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:52 PM
BARON RICHARD A (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:54 PM
Immunome (Issuer)
LAMATTINA JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:55 PM
Immunome (Issuer)
Lefenfeld Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:56 PM
Immunome (Issuer)
Sarma Purnanand D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:57 PM
Immunome (Issuer)
ROBINSON MATTHEW K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:58 PM
Immunome (Issuer)
Roche Corleen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
4:01 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
7:19 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2023
6:30 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IMNM) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners